Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 312

Similar articles for PubMed (Select 21631402)

1.

A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.

Capsoni S, Brandi R, Arisi I, D'Onofrio M, Cattaneo A.

CNS Neurol Disord Drug Targets. 2011 Aug;10(5):635-47. Review.

PMID:
21631402
2.

Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Capsoni S, Tiveron C, Vignone D, Amato G, Cattaneo A.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12299-304. doi: 10.1073/pnas.1007181107. Epub 2010 Jun 21.

3.

On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Capsoni S, Cattaneo A.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):619-33. Epub 2006 Aug 31. Review.

PMID:
16944323
4.

The cholinergic system in aging and neuronal degeneration.

Schliebs R, Arendt T.

Behav Brain Res. 2011 Aug 10;221(2):555-63. doi: 10.1016/j.bbr.2010.11.058. Epub 2010 Dec 9. Review.

PMID:
21145918
5.

Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice.

Capsoni S, Tiveron C, Amato G, Vignone D, Cattaneo A.

J Alzheimers Dis. 2010;20(2):527-46. doi: 10.3233/JAD-2010-091357.

PMID:
20182028
6.

ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice.

Tiveron C, Fasulo L, Capsoni S, Malerba F, Marinelli S, Paoletti F, Piccinin S, Scardigli R, Amato G, Brandi R, Capelli P, D'Aguanno S, Florenzano F, La Regina F, Lecci A, Manca A, Meli G, Pistillo L, Berretta N, Nisticò R, Pavone F, Cattaneo A.

Cell Death Differ. 2013 Aug;20(8):1017-30. doi: 10.1038/cdd.2013.22. Epub 2013 Mar 29.

7.

Development of a non invasive NGF-based therapy for Alzheimer's disease.

Covaceuszach S, Capsoni S, Ugolini G, Spirito F, Vignone D, Cattaneo A.

Curr Alzheimer Res. 2009 Apr;6(2):158-70.

PMID:
19355851
8.

Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype.

Allard S, Leon WC, Pakavathkumar P, Bruno MA, Ribeiro-da-Silva A, Cuello AC.

J Neurosci. 2012 Feb 8;32(6):2002-12. doi: 10.1523/JNEUROSCI.1144-11.2012.

9.

SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.

Capsoni S, Carlo AS, Vignone D, Amato G, Criscuolo C, Willnow TE, Cattaneo A.

J Alzheimers Dis. 2013;33(2):357-71. doi: 10.3233/JAD-2012-121399.

PMID:
22986780
10.

Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.

D'Onofrio M, Arisi I, Brandi R, Di Mambro A, Felsani A, Capsoni S, Cattaneo A.

Neurobiol Aging. 2011 Jun;32(6):1007-22. doi: 10.1016/j.neurobiolaging.2009.05.023. Epub 2009 Jul 14.

PMID:
19604602
11.

Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities.

Houeland G, Romani A, Marchetti C, Amato G, Capsoni S, Cattaneo A, Marie H.

J Neurosci. 2010 Sep 29;30(39):13089-94. doi: 10.1523/JNEUROSCI.0457-10.2010.

12.

Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis.

Cattaneo A, Calissano P.

Mol Neurobiol. 2012 Dec;46(3):588-604. doi: 10.1007/s12035-012-8310-9. Epub 2012 Sep 1. Review.

PMID:
22940884
13.
14.

Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Iulita MF, Do Carmo S, Ower AK, Fortress AM, Aguilar LF, Hanna M, Wisniewski T, Granholm AC, Buhusi M, Busciglio J, Cuello AC.

Brain. 2014 Mar;137(Pt 3):860-72. doi: 10.1093/brain/awt372. Epub 2014 Feb 11.

15.

Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.

Lad SP, Neet KE, Mufson EJ.

Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):315-34. Review.

PMID:
14529363
16.
17.

NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.

Cuello AC, Bruno MA, Bell KF.

Curr Alzheimer Res. 2007 Sep;4(4):351-8. Review.

PMID:
17908036
18.

Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.

Cuello AC, Bruno MA, Allard S, Leon W, Iulita MF.

J Mol Neurosci. 2010 Jan;40(1-2):230-5. doi: 10.1007/s12031-009-9238-z. Epub 2009 Aug 13. Review.

PMID:
19680822
19.

Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC.

Neuron. 2006 Jul 6;51(1):29-42.

20.

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.

De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A.

Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3811-6. Epub 2005 Feb 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk